The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lan, Y. Y.
Right arrow Articles by Thomson, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lan, Y. Y.
Right arrow Articles by Thomson, A. W.
The Journal of Immunology, 2006, 177: 5868-5877.
Copyright © 2006 by The American Association of Immunologists, Inc.

"Alternatively Activated" Dendritic Cells Preferentially Secrete IL-10, Expand Foxp3+CD4+ T Cells, and Induce Long-Term Organ Allograft Survival in Combination with CTLA4-Ig1

Yuk Yuen Lan*,{dagger}, Zhiliang Wang*, Giorgio Raimondi*, Wenhan Wu*, Bridget L. Colvin*, An De Creus* and Angus W. Thomson2,*,{dagger}

* Thomas E. Starzl Transplantation Institute and Department of Surgery and {dagger} Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213

In this study, we propagated myeloid dendritic cells (DC) from BALB/c (H2d) mouse bone marrow progenitors in IL-10 and TGF-beta, then stimulated the cells with LPS. These "alternatively activated" (AA) DC expressed lower TLR4 transcripts than LPS-stimulated control DC and were resistant to maturation. They expressed comparatively low levels of surface MHC class II, CD40, CD80, CD86, and programmed death-ligand 2 (B7-DC; CD273), whereas programmed death-ligand 1 (B7-H1; CD274) and inducible costimulatory ligand expression were unaffected. AADC secreted much higher levels of IL-10, but lower levels of IL-12p70 compared with activated control DC. Their poor allogeneic (C57BL/10; B10) T cell stimulatory activity and ability to induce alloantigen-specific, hyporesponsive T cell proliferation was not associated with enhanced T cell apoptosis. Increased IL-10 production was induced in the alloreactive T cell population, wherein CD4+Foxp3+ cells were expanded. The AADC-expanded allogeneic CD4+CD25+ T cells showed enhanced suppressive activity for T cell proliferative responses compared with freshly isolated T regulatory cells. In vivo migration of AADC to secondary lymphoid tissue was not impaired. A single infusion of BALB/c AADC to quiescent B10 recipients induced alloantigen-specific hyporesponsive T cell proliferation and prolonged subsequent heart graft survival. This effect was potentiated markedly by CTLA4-Ig, administered 1 day after the AADC. Transfer of CD4+ T cells from recipients of long-surviving grafts (>100 days) that were infiltrated with CD4+Foxp3+ cells, prolonged the survival of donor-strain hearts in naive recipients. These data enhance insight into the regulatory properties of AADC and demonstrate their therapeutic potential in vascularized organ transplantation.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants R01 DK49745, R01 AI41011, and R01 AI60994 (to A.W.T.) and by an American Heart Association Predoctoral Fellowship (515403U) (to Y.Y.L.). B.L.C. is the recipient of an American Society of Transplantation Basic Science Fellowship and G.R. is in receipt of a Research Training Fellowship from the Transplantation Society.

2 Address correspondence and reprint requests to Dr. Angus W. Thomson, University of Pittsburgh, W1544 Biomedical Science Tower, 200 Lothrop Street, Pittsburgh, PA 15213. E-mail address: thomsonaw{at}msx.upmc.edu

3 Abbreviations used in this paper: DC, dendritic cell; BM, bone marrow; Treg, regulatory T cell; GVHD, graft-versus-host disease; AADC, alternatively activated DC; Foxp3, Forkhead winged helix protein-3; CM, complete medium; PD-L1, programmed death-ligand 1; MFI, mean fluorescence intensity; PI, propidium iodide; MHC II, MHC class II.




This article has been cited by other articles:


Home page
JEMHome page
J. Li, J. Park, D. Foss, and I. Goldschneider
Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus
J. Exp. Med., March 16, 2009; 206(3): 607 - 622.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A W Thomson and P D Robbins
Tolerogenic dendritic cells for autoimmune disease and transplantation
Ann Rheum Dis, December 1, 2008; 67(Suppl_3): iii90 - iii96.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. R. Herbert, T. Orekov, C. Perkins, and F. D. Finkelman
IL-10 and TGF-{beta} Redundantly Protect against Severe Liver Injury and Mortality during Acute Schistosomiasis
J. Immunol., November 15, 2008; 181(10): 7214 - 7220.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Hauben, S. Gregori, E. Draghici, B. Migliavacca, S. Olivieri, M. Woisetschlager, and M. G. Roncarolo
Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells
Blood, August 15, 2008; 112(4): 1214 - 1222.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Spirig, C. van Kooten, C. Obregon, L. Nicod, M. Daha, and R. Rieben
The Complement Inhibitor Low Molecular Weight Dextran Sulfate Prevents TLR4-Induced Phenotypic and Functional Maturation of Human Dendritic Cells
J. Immunol., July 15, 2008; 181(2): 878 - 890.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. E. Anderson, B. L. Sayers, M. A. Haniffa, D. J. Swan, J. Diboll, X.-N. Wang, J. D. Isaacs, and C. M. U. Hilkens
Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells
J. Leukoc. Biol., July 1, 2008; 84(1): 124 - 133.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. M Blois, U. Kammerer, C. A. Soto, M. C Tometten, V. Shaikly, G. Barrientos, R. Jurd, D. Rukavina, A. W Thomson, B. F Klapp, et al.
Dendritic Cells: Key to Fetal Tolerance?
Biol Reprod, October 1, 2007; 77(4): 590 - 598.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Chen and P. E. Jensen
Cutting Edge: Primary B Lymphocytes Preferentially Expand Allogeneic FoxP3+ CD4 T Cells
J. Immunol., August 15, 2007; 179(4): 2046 - 2050.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. F. Yates, A. M. Paterson, K. F. Nolan, S. P. Cobbold, N. J. Saunders, H. Waldmann, and P. J. Fairchild
Induction of Regulatory T Cells and Dominant Tolerance by Dendritic Cells Incapable of Full Activation
J. Immunol., July 15, 2007; 179(2): 967 - 976.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. R. Turnquist, G. Raimondi, A. F. Zahorchak, R. T. Fischer, Z. Wang, and A. W. Thomson
Rapamycin-Conditioned Dendritic Cells Are Poor Stimulators of Allogeneic CD4+ T Cells, but Enrich for Antigen-Specific Foxp3+ T Regulatory Cells and Promote Organ Transplant Tolerance
J. Immunol., June 1, 2007; 178(11): 7018 - 7031.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.